COLUMBUS, Ga., May 29, 2015 /PRNewswire/ -- Aflac
Incorporated (NYSE: AFL) announced today that Japan Post will be
expanding the number of post offices selling Aflac cancer products
to an additional 10,064 starting July 1,
2015, which will bring the total number of post offices
selling Aflac cancer products to 20,076 throughout Japan.
As stated last week at the company's financial analysts
briefing, Aflac Japan expects third sector sales, which include
cancer and medical products, to grow by an average of 15% for the
first nine months of 2015, and potentially be down significantly in
the fourth quarter due to difficult comparisons from the prior
year's final quarter. As also communicated, the company will share
its expectation for Aflac Japan's full year sales with the second
quarter earnings release scheduled for July
28, 2015.
Aflac Chairman and CEO Dan Amos
commented: "I am extremely pleased that starting in July, more than
20,000 post offices in Japan will
be carrying our cancer insurance products. This expansion further
demonstrates the strength of our strategic alliance with Japan Post
Group and our commitment to working together to be there for the
people throughout all regions of Japan in their time of need."
About Aflac
When a policyholder gets sick or hurt,
Aflac pays cash benefits fast. For nearly six decades, Aflac
insurance policies have given policyholders the opportunity to
focus on recovery, not financial stress. In the United States, Aflac is the leading
provider of voluntary insurance at the work site. Through its
trailblazing One Day PaySM initiative, Aflac U.S. can
receive, process, approve and disburse payment for eligible claims
in one business day. In Japan,
Aflac is a leading provider of medical and cancer insurance and
insures 1 in 4 households. Aflac individual and group insurance
products help provide protection to more than 50 million people
worldwide. For nine consecutive years, Aflac has been recognized by
Ethisphere magazine as one of the World's Most Ethical Companies.
In 2015, Fortune magazine recognized Aflac as one of the 100 Best
Companies to Work For in America for the 17th consecutive year.
Also, in 2015, Fortune magazine included Aflac on its list of Most
Admired Companies for the 14th time, ranking the company number one
in innovation for the insurance, life and health category. Aflac
Incorporated is a Fortune 500 company listed on the New York Stock
Exchange under the symbol AFL. To find out more about Aflac and One
Day PaySM, visit aflac.com or espanol.aflac.com.
Forward-Looking Information
The Private Securities
Litigation Reform Act of 1995 provides a "safe harbor" to encourage
companies to provide prospective information, so long as those
informational statements are identified as forward-looking and are
accompanied by meaningful cautionary statements identifying
important factors that could cause actual results to differ
materially from those included in the forward-looking statements.
We desire to take advantage of these provisions. This document
contains cautionary statements identifying important factors that
could cause actual results to differ materially from those
projected herein, and in any other statements made by company
officials in communications with the financial community and
contained in documents filed with the Securities and Exchange
Commission (SEC).
Forward-looking statements are not based on historical
information and relate to future operations, strategies, financial
results or other developments. Furthermore, forward-looking
information is subject to numerous assumptions, risks and
uncertainties. In particular, statements containing words such as
"expect," "anticipate," "believe," "goal," "objective," "may,"
"should," "estimate," "intends," "projects," "will," "assumes,"
"potential," "target" or similar words as well as specific
projections of future results, generally qualify as
forward-looking. Aflac undertakes no obligation to update such
forward-looking statements. We caution readers that the following
factors, in addition to other factors mentioned from time to time,
could cause actual results to differ materially from those
contemplated by the forward-looking statements: difficult
conditions in global capital markets and the economy; governmental
actions for the purpose of stabilizing the financial markets;
defaults and credit downgrades of securities in our investment
portfolio; exposure to significant financial and capital markets
risk; fluctuations in foreign currency exchange rates; significant
changes in investment yield rates; credit and other risks
associated with Aflac's investment in perpetual securities;
differing judgments applied to investment valuations; significant
valuation judgments in determination of amount of impairments taken
on our investments; limited availability of acceptable
yen-denominated investments; concentration of our investments in
any particular single-issuer or sector; concentration of business
in Japan; decline in
creditworthiness of other financial institutions; deviations in
actual experience from pricing and reserving assumptions;
subsidiaries' ability to pay dividends to Aflac Incorporated;
ineffective risk management policies and procedures; changes in law
or regulation by governmental authorities; ability to attract and
retain qualified sales associates and employees; decreases in our
financial strength or debt ratings; ability to continue to develop
and implement improvements in information technology systems;
interruption in telecommunication, information technology and other
operational systems, or a failure to maintain the security,
confidentiality or privacy of sensitive data residing on such
systems; changes in U.S. and/or Japanese accounting standards;
failure to comply with restrictions on patient privacy and
information security; level and outcome of litigation; ability to
effectively manage key executive succession; catastrophic events
including, but not necessarily limited to, epidemics, pandemics,
tornadoes, hurricanes, earthquakes, tsunamis, acts of terrorism and
damage incidental to such events; ongoing changes in our industry;
events that damage our reputation; increased expenses for pension
and other postretirement plans; and failure of internal controls or
corporate governance policies and procedures.
Logo -
http://photos.prnewswire.com/prnh/20100423/CL92305LOGO
Analyst and investor contact – Robin Y.
Wilkey, 706.596.3264 or 800.235.2667; FAX: 706.324.6330 or
rwilkey@aflac.com
Media contact – Catherine Blades,
706.596.3014; FAX: 706.320.2288 or cblades@aflac.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aflac-japan-cancer-products-to-be-available-in-20000-japan-postal-outlets-300090785.html
SOURCE Aflac Incorporated